Immunological mechanisms in specific immunotherapy

Springer Seminars in Immunopathology

Volumn 25, Issue 3-4, 2004, Pages 377-390

  Schmidt Weber, Carsten B ^a   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Allergy; Regulatory T cells; Specific immunotherapy

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CYCLOSPORIN A; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; RAPAMYCIN; STEROID; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VACCINE;

ALLERGY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; APOPTOSIS; ASTHMA; ATOPY; B LYMPHOCYTE ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; CLINICAL TRIAL; CLONAL ANERGY; DERMATOPHAGOIDES; DRUG MECHANISM; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; NONHUMAN; PHENOTYPE; POLLEN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIDE EFFECT; SPECIFIC IMMUNOTHERAPY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; ASTHMA; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; T-LYMPHOCYTES;

EID: 1442308171     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-003-0147-x     Document Type: Review

References (128)

1. Lerch E, Muller UR (1998) Long-term protection after stopping venom immunotherapy: results of restings in 200 patients. J Allergy Clin Immunol 101:606
2. Durham SR, Walker SM, Varga EM, et al (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341:468
3. Bousquet J, Demoly P, Michel FB (2001) Specific immunotherapy in rhinitis and asthma. Ann Allergy Asthma Immunol 87:38
4. Rak S, Heinrich C, Jacobsen L, et al (2001) A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 108:921
5. Gruber W, Eber E, Mileder P, et al (1999) Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients. Clin Exp Allergy 29:176
6. Cantani A, Arcese G, Lucenti P, et al (1997) A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma. J Invest Allergol Clin Immunol 7:90
7. Carballido JM, Faith A, Carballido-Perrig N, et al (1997) The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur J Immunol 27:515
8. Walker C, Bode E, Boer L, et al (1992) Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146:109
9. Walker C, Kagi MK, Ingold P, et al (1993) Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 23:145
10. Walker C, Virchow JC Jr, Bruijnzeel PL, et al (1991) T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 146:1829
11. Blaser K, Carballido J, Faith A, et al (1998) Determinants and mechanisms of human immune responses to bee venom phospholipase A2. Int Arch Allergy Immunol 117:1
12. Durham SR, Till SJ (1998) Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 102:157
13. Vrtala S, Hirtenlehner K, Susani M, et al (2001) Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J 15:2045
14. Valenta R, Kraft D (2001) Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev 179:119
15. Akdis CA, Blaser K (1999) IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 13:603
16. Akdis CA, Blesken T, Akdis M, et al (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102:98
17. Bellinghausen I, Metz G, Enk AH, et al (1997) Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 27:1131
18. Jutel M, Akdis M, Budak F, et al (2003) IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33:1205
19. Jutel M, Akdis M, Budak F, et al (2001) IL-10 and TGF-β cooperate in inducing peripheral T cell tolerance during specific immunotherapy with inhalant allergens and during natural allergen exposure. J Allergy Clin Immunol 107:590
20. Schmidt-Weber CB, Blaser K (2002) T-cell tolerance in allergic response. Allergy 57:762
21. Schmidt-Weber CB, Kunzmann S, Blaser K (2002) TGF-beta-mediated control of allergen-specific T-cell responses. Curr Allergy Asthma Rep 2:259
22. Chen Y, Kuchroo VK, Inobe J, et al (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237
23. + T cells. J Exp Med 184:19
24. Asseman C, Mauze S, Leach MW, et al (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995
25. Groux H, O'Garra A, Bigler M, et al (1997) A Cd4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737
26. Qin L, Ding Y, Pahud DR, et al (1997) Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 8:1365
27. Cobbold S, Waldmann H (1998) Infectious tolerance. Curr Opin Immunol 10:518
28. D'Orazio TJ, Niederkorn JY (1998) A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 160:2089
29. Zhai Y, Kupiec-Weglinski JW (1999) What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 11:497
30. Mottet C, Uhlig HH, Powrie F (2003) Cutting edge: cure of colitis by CD4(+)CD25(+) regulatory T cells. J Immunol 170:3939
31. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197:111
32. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212
33. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30:1538
34. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287
35. Shevach EM, McHugh RS, Piccirillo CA, et al (2001) Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 182:58
36. Jonuleit H, Schmitt E, Kakirman H, et al (2002) Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 196:255
37. Stinchcombe JC, Griffiths GM (2001) Normal and abnormal secretion by haemopoietic cells. Immunology. 103:10
38. Nakamura K, Kitani A, Strober W (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629
39. + memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J Immunol 159:4611
40. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388
41. + T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 31:1637
42. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat Immunol 4:330
43. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057
44. Schubert LA, Jeffery E, Zhang Y, et al (2001) Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276:37672
45. Guerder S, Flavell RA (1995) Costimulation in tolerance and autoimmunity. Int Rev Immunol 13:135
46. Liu L, Kuchroo VK, Weiner HL (1999) B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance. J Immunol 163:2284
47. Adorini L (2000) Inhibition of dendritic cell costimulation associated with tolerance to allografts. Eur Cytokine Netw 11:508
48. Van Parijs L, Ibraghimov A, Abbas AK (1996) The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321
49. Pages F, Ragueneau M, Rottapel R, et al (1994) Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling [published erratum appears in Nature (1994) 370:157]. Nature 369:327
50. Brennan P, Babbage JW, Burgering BM, et al (1997) Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679
51. Joss A, Akdis M, Faith A, et al (2000) IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol 30:1683
52. Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290:84
53. Marte BM, Downward J (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22:355
54. Schmidt-Weber CB, Wohlfahrt JG, Akdis C, et al (2002) The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells. Eur J Immunol 32:1196
55. Dong Y, Tang L, Letterio JJ, et al (2001) The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression. J Immunol 167:311
56. Petritsch C, Beug H, Balmain A, et al (2000) TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 14:3093
57. Choudhry MA, Sir O, Sayeed MM (2001) TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells. Shock 15:193
58. + suppressor T cells: more questions than answers. Nat Rev Immunol 2:389
59. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787
60. Li Y, Simons FE, Jay FT, et al (1996) Allergen-driven limiting dilution analysis of human IL-4 and IFN-gamma production in allergic rhinitis and clinically tolerant individuals. Int Immunol 8:897
61. Trautmann A, Schmid-Grendelmeier P, Kruger K, et al (2002) T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol 109:329
62. Trautmann A, Akdis M, Kleemann D, et al (2000) T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106:25
63. Wong CK, Ho CY, Ko FW, et al (2001) Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 125:177
64. Magnan A, Pee D van, Bongrand P, et al (1998) Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy 53:1092
65. Smits HH, Rietschoten JG van, Hilkens CM, et al (2001) IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. Eur J Immunol 31:1055
66. Hilkens CM, Messer G, Tesselaar K, et al (1996) Lack of IL-12 signaling in human allergen-specific Th2 cells. J Immunol 157:4316
67. De Wit D, Amraoui Z, Vincart B, et al (2000) Helper T-cell responses elicited by Der p 1-pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects. J Allergy Clin Immunol 105:346
68. Sakaguchi S (2000) Regulatory T cells: key controllers of immunological self-tolerance. Cell 101:455
69. Bellinghausen I, Knop J, Saloga J (2001) The role of interleukin 10 in the regulation of allergic immune responses. Int Arch Allergy Immunol 126:97
70. Caramalho I, Lopes-Carvalho T, Ostler D, et al (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197:403
71. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991
72. Vrtala S, Akdis CA, Budak F, et al (2000) T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol 165:6653
73. Ferreira F, Ebner C, Kramer B, et al (1998) Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 12:231
74. Muller U, Akdis CA, Fricker M, et al (1998) Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 101:747
75. Oldfield WL, Larche M, Kay AB (2002) Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360:47
76. + T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163:2944
77. Boussiotis VA, Freeman GJ, Berezovskaya A, et al (1997) Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rapl. Science 278:124
78. Beverly B, Kang SM, Lenardo MJ, et al (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4:661
79. Boussiotis VA, Barber DL, Nakarai T, et al (1994) Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 266:1039
80. Fortis C, Clementi E (1997) Reversible lymphocyte anergy during IL-2 therapy. Immunol Today 18:254
81. Akdis CA, Akdis M, Blesken T, et al (1996) Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 98:1676
82. Ewan PW (2001) New insight into immunological mechanisms of venom immunotherapy. Curr Opin Allergy Clin Immunol 1:367
83. Rafiq K, Charitidou L, Bullens DM, et al (2001) Regulation of the IL-10 production by human T cells. Scand J Immunol 53:139
84. Cohen SB, Parry SL, Feldmann M, et al (1997) Autocrine and paracrine regulation of human T cell IL-10 production. J Immunol 158:5596
85. Johnson EN, Druey KM (2002) Heterotrimeric G protein signaling: role in asthma and allergic inflammation. J Allergy Clin Immunol 109:592
86. Stankova J, Gagnon N, Rola-Pleszczynski M (1992) Leukotriene B4 augments interleukin-2 receptor-beta (IL-2R beta) expression and IL-2R beta-mediated cytotoxic response in human peripheral blood lymphocytes. Immunology 76:258
87. Vang T, Torgersen KM, Sundvold V, et al (2001) Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 193:497
88. Santamaria LF, Torres R, Ryder H, et al (1999) Prostaglandin E2 inhibits SEB-mediated induction of the cutaneous lymphocyte-associated antigen. Int Arch Allergy Immunol 118:351
89. Kabashima K, Saji T, Murata T, et al (2002) The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109:883
90. Poluektova LY, Huggler GK, Patterson EB, et al (1999) Involvement of protein kinase A in histamine-mediated inhibition of IL-2 mRNA expression in mouse splenocytes. Immunopharmacology 41:77
91. Jutel M, Watanabe T, Klunker S, et al (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420
92. Hur EM, Kim KT (2002) G protein-coupled receptor signalling and cross-talk. Achieving rapidity and specificity. Cell Signal 14:397
93. Brady AE. Limbird LE (2002) G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell Signal 14:297
94. Neves SR, Ram PT, Iyengar R (2002) G protein pathways. Science 296:1636
95. Chen D, Rothenberg EV (1994) Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 179:931
96. Osna N, Elliott K, Khan MM (2001) The effects of histamine on interferon gamma production are dependent on the stimulatory signals. Int Immunopharmacol 1:135
97. Osna N, Elliott K, Khan MM (2001) Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes. Int Immunopharmacol 1:85
98. Hol BE, Krouwels FH, Bruinier B, et al (1993) Heterogeneous effects of histamine on proliferation of lung-and blood-derived T-cell clones from healthy and asthmatic persons. Am J Respir Cell Mol Biol 8:647
99. Kunzmann S, Mantel PY, Wohlfahrt JG, et al (2003) Histamine enhances TGF-beta mediated suppression of Th2 responses. FASEB J 17:1089
100. Nielsen L, Johnsen CR, Mosbech H, et al (1996) Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 97:1207
101. Brockow K, Kiehn M, Riethmuller C, et al (1997) Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100:458
102. Reimers A, Hari Y, Muller U (2000) Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 55:484
103. Muller U, Hari Y, Berchtold E (2001) Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 107:81
104. Kuehr J, Brauburger J, Zielen S, et al (2002) Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 109:274
105. Frieri M (1999) Corticosteroid effects on cytokines and chemokines. Allergy Asthma Proc 20:147
106. Fauci AS (1975) Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and B lymphocytes to the bone marrow. Immunology 28:669
107. Balow JE, Hurley DL, Fauci AS (1975) Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity. J Immunol 114:1072
108. Bauer ME, Papadopoulos A, Poon L, et al (2002) Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression. Psychiatry Res 113:1
109. Fryer CJ, Archer TK (1998) Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393:88
110. Fletcher TM, Ryu BW, Baumann CT, et al (2000) Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition. Mol Cell Biol 20:6466
111. Agarwal S, Rao A (1998) Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765
112. Barrat FJ, Cua DJ, Boonstra A, et al (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 195:603
113. Sade K, Kivity S, Levy A, et al (2003) The effect of specific immunotherapy on T-cell receptor repertoire in patients with allergy to house-dust mite. Allergy 58:430
114. Guerra F, Carracedo J, Solana-Lara R, et al (2001) TH2 lymphocytes from atopic patients treated with immunotherapy undergo rapid apoptosis after culture with specific allergens. J Allergy Clin Immunol 107:647
115. De Amici M, Puggioni F, Casali L, et al (2001) Variations in serum levels of interleukin (IL)-1beta, IL-2, IL-6, and tumor necrosis factor-alpha during specific immunotherapy. Ann Allergy Asthma Immunol 86:311
116. Fleva A, Daniilidis M, Sidiropoulos J, et al (2001) Can HLA typing predict the outcome of grass pollen immunotherapy? Exp Clin Immunogenet 18:13
117. Andre C, Vatrinet C, Galvain S, et al (2000) Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 121:229
118. Eng PA, Reinhold M, Gnehm HP (2002) Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 57:306
119. Wuthrich B, Gumowski PL, Fah J, et al (2001) Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide. J Invest Allergol Clin Immunol 11:149
120. Drachenberg KJ, Proll S, Urban E, et al (2003) Single-course specific immunotherapy with mixed pollen allergoids: results of a multi-centre study. Allergol Immunopathol (Madr) 31:77
121. Cirla AM, Cirla PE, Parmiani S, et al (2003) A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Allergol Immunopathol 31:31
122. Di Bernardino C, Di Bernardino F, Colombo R, et al (2002) A case control study of dermatophagoides immunotherapy in children below 5 years of age. Allerg Immunol 34:56
123. Pajno GB, Barberio G, De Luca F, et al (2001) Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 31:1392
124. Pichler CE, Helbling A, Pichler WJ (2001) Three years of specific immunotherapy with house-dustmite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 56:301
125. Grembiale RD, Camporota L, Naty S, et al (2000) Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 162:2048
126. Obtulowicz K, Cichocka-Jarosz E (1998) Induction of allergy to new aeroallergens during specific immunotherapy (SIT) in grass pollen sensitive patients. Allerg Immunol (Paris) 30:250
127. Asero R (2003) How long does the effect of birch pollen injection SIT on apple allergy last? Allergy 58:435
128. Pifferi M, Baldini G, Marrazzini G, et al (2002) Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy 57:785